Promoter holding
64.27%
SA
Sailife - Due diligence report
A 360° intelligence report on Sailife: trust score, financial health, credit view, compliance, directors, growth and distress signals - gene…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Sailife — 360° Intelligence Report
Generated from MCA filings & public records91/100
Trust Score
Low Risk
Sailife is assessed as Low Risk with a Trust Score of 91/100. Sailife is an active public limited indian non-government company incorporated in 1999, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 29 Sep 2026 from the latest processed filings. Sai Life Sciences Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
91/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
85/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Profitable - internal accruals available.
Charges position: 5 open (962.36 cr) · 33 satisfied (1,590.09 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Sbicap Trustee Company Limited | 10 | 48.0 cr |
| State Bank Of India | 11 | 48.0 cr |
| Others | 5 | 48.0 cr |
| The Hongkong And Shanghai Banking Corporation Limited | 1 | 48.0 cr |
| State Bank Of Hyderabad | 2 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
Compliance Score: 85/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- Delayed payments to MSME suppliers disclosed (284 disclosure(s)).
- 3 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| KRISHNAMRAJU KANUMURI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SIVARAMAKRISHNAN CHITTOR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RANGA RAJU KANUMURI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Suchita Sharma | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAMESH GANESH IYER | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Dinesh V Patel | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 6 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
39 allotment(s) · 1 transfer(s)
Promoters hold the largest single block of equity - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Sai Life Pharma Private Limited | Subsidiary Company | 74.00% |
| Sai Life Sciences Gmbh | Subsidiary Company | 74.00% |
| Sai Life Sciences Inc | Subsidiary Company | 74.00% |
Key managerial personnel: KRISHNAMRAJU KANUMURI (Managing Director) · SIVARAMAKRISHNAN CHITTOR (Whole-time director) · RANGA RAJU KANUMURI (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Net margin improved to 61%.
EPFO headcount growing - hiring signal.
Operating for 27+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
5 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 2.28 cr.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment90/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 5 open charge(s) of 962.36 cr already registered.
- Compliance record supports lending.
Investor view94/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events13 Mar 2026
Charge created
Axis Bank Limited - 50.00 cr
11 Sep 2025
Last AGM held
Annual general meeting
28 Apr 2025
Director appointed
SIVARAMAKRISHNAN CHITTOR (Whole-time director)
31 Mar 2025
Latest balance sheet
Filed with ROC
26 Mar 2025
Charge satisfied
Sbicap Trustee Company Limited
24 Mar 2025
Director appointed
Dinesh V Patel (Director)
25 Jul 2024
Charge satisfied
Hdfc Bank Limited
10 Jun 2024
Director appointed
Suchita Sharma (Director)
06 Jun 2024
Director ceased
RAJU PENMASTA
04 Jun 2024
Charge satisfied
Sbicap Trustee Company Limited
21 May 2024
Director appointed
RAMESH GANESH IYER (Director)
29 Apr 2024
Charge satisfied
The Hongkong And Shanghai Banking Corporation Limited
26 Mar 2024
Charge satisfied
Others
20 Feb 2024
Charge satisfied
Others
14 Feb 2024
Charge satisfied
Others
10
Key Observations
Auto-generated from the data aboveRevenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
6 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold the largest single block of equity as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 39 security allotment(s) - amounts available in the full report.
8 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Encube Ethicals | U24230MH1995PLC092485 | Mumbai, Maharashtra, India |
| Edictpharmaceuticals | U33111TN1982PTC009602 | Chennai, Tamil Nadu, India |
| Novozymes | U24299KA1998PTC024038 | Bangalore, Karnataka, India |
| Unilever Industries Private Limited | U24110MH1994PTC081672 | Mumbai, Maharashtra, India |
| Anthem Biosciences | L24233KA2006PLC039703 | Bangalore, Karnataka, India |
| Mitsuba India Private Limited | U34300TN2000PTC046158 | Chennai, Tamil Nadu, India |
| Pfizer | U24232TN2009PTC073563 | Chennai, Tamil Nadu, India |
| Rellife | U24239MH2001PTC130654 | Navi Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Sailife before audits and certifications: compliance score 85/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Sailife: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Sailife - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 91/100, distress signals and MSME payment-delay disclosures - know whether Sailife pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Sailife - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Sailife an active company?
Sailife has MCA status “Active” with a compliance score of 85/100 (Low Risk).
Is Sailife financially healthy?
Sailife has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Sailife?
Its overall Trust Score is 91/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Sailife?
Promoters hold the largest single block of equity - exact percentages are in the full report. 6 active director(s) are on record.
Does Sailife have loans or charges against its assets?
5 open charge(s) are registered against its assets, and 33 earlier charge(s) stand satisfied.
Is Sailife up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 85/100 (Low Risk).
Is it risky to lend to Sailife?
Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
